(S)-1-(3,4-dimethylphenyl)ethaneamine | 1212186-90-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (S)-1-(3,4-dimethylphenyl)ethaneamine
• 英文别名: (1S)-1-(3,4-dimethylphenyl)ethan-1-amine；(1S)-1-(3,4-dimethylphenyl)ethanamine
• CAS: 1212186-90-7
• 化学式: C₁₀H₁₅N
• mdl: MFCD06761921
• 分子量: 149.236
• InChiKey: PMUVPGYHXWUERM-VIFPVBQESA-N

物化性质

• 沸点：
  233.6±9.0 °C(Predicted)
• 密度：
  0.937±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

反应信息

• 作为反应物：
  描述：

  (S)-1-(3,4-dimethylphenyl)ethaneamine 、 3-(4-氧代-3,4-二氢-2-喹唑啉)-丙酸 在 三乙胺 、 N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 以52%的产率得到(S)-N-(1-(3,4-dimethylphenyl)ethyl)-3-(4-oxo-3H-quinazolin-2-yl)propanamide
  参考文献：
  名称：

  Chemical Probes to Study ADP-Ribosylation: Synthesis and Biochemical Evaluation of Inhibitors of the Human ADP-Ribosyltransferase ARTD3/PARP3

  摘要：

  The racemic 3-(4-oxo-3,4-dihydroquinazolin-2-yl)-N-[1-(pyridin-2-yl)ethyl]propanamide, 1, has previously been identified as a potent but unselective inhibitor of diphtheria toxin-like ADP-ribosyltransferase 3 (ARTD3). Herein we describe synthesis and evaluation of SS compounds in this class. It was found that the stereochemistry is of great importance for both selectivity and potency and that substituents on the phenyl ring resulted in poor solubility. Certain variations at the meso position were tolerated and caused a large shift in the binding pose. Changes to the ethylene linker that connects the quinazolinone to the amide were also investigated but proved detrimental to binding. By combination of synthetic organic chemistry and structure-based design, two selective inhibitors of ARTD3 were discovered.

  DOI：

  10.1021/jm401394u
• 作为产物：
  描述：

  3,4-二甲基苯乙酮 在 (氨基甲基)-苯酚 、 C₂₄H₃₄N₂O₂ 、 盐酸 作用下， 以 甲苯 、 四氢呋喃 、 水 为溶剂， 反应 96.0h， 以83% ee的产率得到
  参考文献：
  名称：

  芳族酮的有机催化不对称仿生氨基转移为旋光胺†

  摘要：

  描述了由氢醌衍生的手性碱催化的邻-HOPhCH 2 NH 2作为胺源的芳香族酮的不对称仿生氨基转移成旋光胺。获得了高达85％的ee。

  DOI：

  10.1039/c2ob26782a

文献信息

• Heterobicyclic metalloprotease inhibitors
  申请人：Nolte Bert

  公开号：US20080176870A1

  公开（公告）日：2008-07-24

  The present invention relates generally to heterobicyclic containing pharmaceutical agents, and in particular, to heterobicyclic metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of heterobicyclic metalloprotease inhibiting compounds that exhibit an increased potency in relation to currently known metalloprotease inhibitors.

  本发明涉及含有杂环的药物，特别是含有杂环的金属蛋白酶抑制剂化合物。更具体地说，本发明提供了一类新的杂环金属蛋白酶抑制剂化合物，其相对于当前已知的金属蛋白酶抑制剂表现出更高的效力。
• MALONAMIDE DERIVATIVES WITH ANTITHROMBOTIC ACTIVITY
  申请人：STEINHAGEN Henning

  公开号：US20100249101A1

  公开（公告）日：2010-09-30

  The present invention relates to compounds of formula I, The compounds of formula I are valuable pharmacologically active compounds. They exhibit a strong anti-thrombotic effect and are suitable, for example, for the therapy and prophylaxis of cardio-vascular disorders like thromboembolic diseases or restenoses. They are inhibitors of the blood clotting enzymes, especially factor VIIa and can in general be applied in conditions in which an undesired activity of factor VIIa is present or for the cure or prevention of which an inhibition of factor VIIa is intended. The invention furthermore relates to processes for the preparation of compounds of formula I, their use, in particular as active ingredients in pharmaceuticals, and pharmaceutical preparations comprising them.

  本发明涉及式I的化合物，式I的化合物是有价值的药理活性化合物。它们表现出强烈的抗血栓作用，适用于治疗和预防心血管疾病，如血栓栓塞性疾病或再狭窄。它们是血凝酶酶的抑制剂，特别是因子VIIa，通常可应用于因子VIIa不良活性存在的情况或治愈或预防需要抑制因子VIIa的情况。此外，本发明还涉及式I化合物的制备方法，它们的用途，特别是作为药物的活性成分，以及包含它们的制药制剂。
• Chemical Probes to Study ADP-Ribosylation: Synthesis and Biochemical Evaluation of Inhibitors of the Human ADP-Ribosyltransferase ARTD3/PARP3
  作者：Anders E. G. Lindgren、Tobias Karlberg、Torun Ekblad、Sara Spjut、Ann-Gerd Thorsell、C. David Andersson、Ton Tong Nhan、Victor Hellsten、Johan Weigelt、Anna Linusson、Herwig Schüler、Mikael Elofsson

  DOI：10.1021/jm401394u

  日期：2013.12.12

  The racemic 3-(4-oxo-3,4-dihydroquinazolin-2-yl)-N-[1-(pyridin-2-yl)ethyl]propanamide, 1, has previously been identified as a potent but unselective inhibitor of diphtheria toxin-like ADP-ribosyltransferase 3 (ARTD3). Herein we describe synthesis and evaluation of SS compounds in this class. It was found that the stereochemistry is of great importance for both selectivity and potency and that substituents on the phenyl ring resulted in poor solubility. Certain variations at the meso position were tolerated and caused a large shift in the binding pose. Changes to the ethylene linker that connects the quinazolinone to the amide were also investigated but proved detrimental to binding. By combination of synthetic organic chemistry and structure-based design, two selective inhibitors of ARTD3 were discovered.
• Organocatalytic asymmetric biomimetic transamination of aromatic ketone to optically active amine
  作者：Ying Xie、Hongjie Pan、Xiao Xiao、Songlei Li、Yian Shi

  DOI：10.1039/c2ob26782a

  日期：——

  An asymmetric biomimetic transamination of aromatic ketones to optically active amines with o-HOPhCH2NH2 as amine source catalyzed by hydroquinine-derived chiral base is described. Up to 85% ee was obtained.

  描述了由氢醌衍生的手性碱催化的邻-HOPhCH 2 NH 2作为胺源的芳香族酮的不对称仿生氨基转移成旋光胺。获得了高达85％的ee。